Rasalect 0.5 Tablet
Marketer
Sun Pharmaceutical Industries Ltd
Salt Composition
Rasagiline (0.5mg)
Overview Rasalect 0.5 Tablet
Parkinson's disease is managed with Rasalect 0.5mg tablets, which improve motor control and reduce tremors and rigidity. This medication can be used independently or alongside other treatments, with or without food. Consistent daily dosing ensures stable drug levels. Always adhere to your physician's prescribed dosage and duration. If a dose is missed, take it immediately upon recollection; avoid skipping doses and complete the entire course, even with symptom improvement. Abrupt cessation is dangerous and may cause disorientation, muscle stiffness, and pyrexia; consult your doctor before stopping. Potential side effects include arthralgia, sleep disturbances, dyspepsia, flu-like symptoms, depressive episodes, cough, and peripheral edema. Dizziness and somnolence are possible; avoid activities requiring alertness until the medication's effects are known. Regular skin cancer screenings are recommended due to increased risk. Report any unusual mood shifts, hallucinations, hypersexuality, compulsive gambling, or excessive spending to your doctor immediately due to potential serious implications.
Primary Ingredients of Rasalect 0.5 Tablet
The provided text is "undefined," which has no meaning to rephrase. Therefore, no rewritten text can be provided.
Uses of Rasalect 0.5 Tablet
Managing Parkinson's disease
Major Benefits of Rasalect 0.5 Tablet:
Administer Rasalect 0.5 Tablet as prescribed by your physician, adhering to the recommended dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Consumption with or without food is acceptable, though consistent timing is preferred.
Common Side effects of Rasalect 0.5 Tablet:
- Joint pain
- Insomnia (difficulty in sleeping)
- Indigestion
- Flu-like symptoms
- Depression
- Cough
- Peripheral edema
How to use Rasalect 0.5 Tablet:
Administer this medication precisely as your physician directs, adhering to the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Rasalect 0.5mg tablets can be consumed with or without food, though consistent timing is recommended.
How Rasalect 0.5 Tablet works:
Rasalect 0.5mg tablets enhance brain dopamine levels, a neurotransmitter crucial for motor control.
SAFETY ADVICE
AlcoholUNSAFE
Combining Rasalect 0.5 Tablet and alcohol is inadvisable.
PregnancyCONSULT YOUR DOCTOR
The use of Rasalect 0.5 Tablet during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to the unborn child. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice before taking this medication.
Breast feedingCONSULT YOUR DOCTOR
Lactation and the use of Rasalect 0.5mg tablets are likely incompatible. Available human data indicate potential transfer of the medication into breast milk, posing a possible risk to the infant.
DrivingUNSAFE
Taking Rasalect 0.5 Tablet may cause drowsiness, blurred vision, and dizziness, reducing alertness. Driving should be avoided if these effects are experienced.
KidneySAFE IF PRESCRIBED
The use of Rasalect 0.5 Tablet in individuals with kidney disease appears to pose minimal risk. Preliminary evidence indicates dose modification may not be necessary; however, physician consultation is recommended.
LiverCAUTION
Patients with liver impairment should use Rasalect 0.5 Tablet cautiously, potentially requiring dosage modification. Consult a physician before use. Rasalect 0.5 Tablet is contraindicated in individuals with moderate to severe hepatic dysfunction.
What if you forget to take Rasalect 0.5 Tablet :
Should you forget to take a Rasalect 0.5 Tablet, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Rasalect 0.5 Tablet
| Label | Value |
|---|---|
| Chemical Type | Indane Byproduct |
| Developing Habits | No. |
| Treatment Category | Neuroscience |
| Action Class | MAO-B Inhibition |





